PCN28 Budget Impact Analysis of Everolimus for ER+, HER2- Metastatic Breast Cancer Patients in the United States
2012 ◽
Vol 15
(4)
◽
pp. A212
J. Xie
◽
M. Diener
◽
G. De
◽
E.Q. Wu
◽
M. Namjoshi
2014 ◽
Vol 17
(7)
◽
pp. A622
G. Elsisi
◽
E. Saeed
◽
M. Elmahdawy
S.S. Mougalian
◽
J. Zhang
◽
J.K. Kish
◽
M.E. Zettler
◽
B.A. Feinberg
A Liede
◽
RK Hernandez
◽
M Pirolli
◽
J Quigley
◽
D Quach
S.S. Mougalian
◽
J.K. Kish
◽
J. Zhang
◽
T. Miller
◽
D. Liassou
◽
...
J. Zhou
◽
M.L. Edwards
◽
H. Fang
◽
G. Oderda
◽
D. Brixner
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. e16500-e16500
K. L. Davis
◽
S. Iyer
◽
S. Candrilli
Giovanni Zanotti
◽
Matthias Hunger
◽
Julia J Perkins
◽
Ruslan Horblyuk
◽
Monique Martin
2012 ◽
Vol 16
(1)
◽
pp. 96-107
◽
Laure Benjamin
◽
Valérie Buthion
◽
Michaël Iskedjian
◽
Bechara Farah
◽
Catherine Rioufol
◽
...
Seri AL Anderson
◽
Justin Carrico
◽
Thor-Henrik Brodtkorb
◽
Deepa Lalla
◽
Adam Brufsky
2005 ◽
Vol 8
(3)
◽
pp. 344
M Botteman
◽
M Aapro
◽
JW Hay
◽
J Stephens
◽
J Brandman